The Microbiome and Cancer: Is the 'Oncobiome' Mirage Real?

Trends in Cancer

Volumn 1, Issue 1, 2015, Pages 24-35

  Thomas, Ryan M ^a,b   Jobin, Christian ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GROWTH; CARCINOGENESIS; CARCINOGENIC ACTIVITY; HOST; HUMAN; IMMUNE SYSTEM; INFLAMMATION; MALIGNANT NEOPLASTIC DISEASE; MICROBIAL COMMUNITY; MICROBIOME; MICROFLORA; MICROORGANISM; NONHUMAN; PATHOGENESIS; REVIEW;

EID: 84957795451     PISSN: 24058033     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trecan.2015.07.005     Document Type: Review

References (166)

1. S.R. Gill, and et al. Metagenomic analysis of the human distal gut microbiome Science 312 2006 1355 1359
2. J. Qin, and et al. A human gut microbial gene catalogue established by metagenomic sequencing Nature 464 2010 59 65
3. M. Rajilic-Stojanovic, and et al. Diversity of the human gastrointestinal tract microbiota revisited Environ. Microbiol. 9 2007 2125 2136
4. Human Microbiome Project Consortium Structure, function and diversity of the healthy human microbiome Nature 486 2012 207 214
5. P.S. Moore, and Y. Chang Why do viruses cause cancer? Highlights of the first century of human tumour virology Nat. Rev. Cancer 10 2010 878 889
6. F. Sommer, and F. Backhed The gut microbiota - masters of host development and physiology Nat. Rev. Microbiol. 11 2013 227 238
7. B.J. Marshall, and J.R. Warren Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration Lancet 1 1984 1311 1315
8. R.M. Peek Jr., and J.E. Crabtree Helicobacter infection and gastric neoplasia J. Pathol. 208 2006 233 248
9. D.M. Hardbower, and et al. Chronic inflammation and oxidative stress: the smoking gun for Helicobacter pylori-induced gastric cancer? Gut Microbes 4 2013 475 481
10. M. Koeppel, and et al. Helicobacter pylori infection causes characteristic DNA damage patterns in human cells Cell Rep. 11 2015 1703 1713
11. L.E. Wroblewski, and R.M. Peek Jr. Helicobacter pylori in gastric carcinogenesis: mechanisms Gastroenterol. Clin. North Am. 42 2013 285 298
12. IARC Working Group Infection with Helicobacter pylori. In IARC Monographs on the Evaluation of Carcinogenic Risks to Humans (Vol. 61) Schistosomes, Liver Flukes, and Helicobacter pylori 1994 WHO International Agency for Research on Cancer 177 240
13. C. de Martel, and et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis Lancet Oncol. 13 2012 607 615
14. B.C. Wong, and et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial JAMA 291 2004 187 194
15. Pan, K.F. et al. (2015) A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication. Gut Published online May 18, 2015. PMID: 25986943.
16. A.C. Ford, and et al. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials BMJ 348 2014 g3174
17. J. Ahn, and et al. Human gut microbiome and risk for colorectal cancer J. Natl. Cancer Inst. 105 2013 1907 1911
18. M. Castellarin, and et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma Genome Res. 22 2012 299 306
19. W. Chen, and et al. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer PLoS ONE 7 2012 e39743
20. A.D. Kostic, and et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma Genome Res. 22 2012 292 298
21. J.R. Marchesi, and et al. Towards the human colorectal cancer microbiome PLoS ONE 6 2011 e20447
22. A.N. McCoy, and et al. Fusobacterium is associated with colorectal adenomas PLoS ONE 8 2013 e53653
23. N. Sanapareddy, and et al. Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans ISME J. 6 2012 1858 1868
24. I. Sobhani, and et al. Microbial dysbiosis in colorectal cancer (CRC) patients PLoS ONE 6 2011 e16393
25. T. Wang, and et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers ISME J. 6 2012 320 329
26. N. Wu, and et al. Dysbiosis signature of fecal microbiota in colorectal cancer patients Microb. Ecol. 66 2013 462 470
27. W. Russell An address on a characteristic organism of cancer Br. Med. J. 2 1890 1356 1360
28. V. Wuerthele-Caspe, and et al. Cultural properties and pathogenicity of certain microorganisms obtained from various proliferative and neoplastic diseases Am. J. Med. Sci. 220 1950 638 646
29. V. Aries, and et al. Bacteria and the aetiology of cancer of the large bowel Gut 10 1969 334 335
30. S.M. Crusz, and F.R. Balkwill Inflammation and cancer: advances and new agents Nat. Rev. Clin. Oncol. 2015 10.1038/nrclinonc.2015.105 Published online June 30, 2015
31. A. Mantovani, and et al. Cancer-related inflammation Nature 454 2008 436 444
32. E. Elinav, and et al. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms Nat. Rev. Cancer 13 2013 759 771
33. E. Punkenburg, and et al. Batf-dependent Th17 cells critically regulate IL-23 driven colitis-associated colon cancer Gut 2015 10.1136/gutjnl-2014-308227 Published online April 2, 2015
34. I. Tiniakou, and et al. High-density lipoprotein attenuates Th1 and Th17 autoimmune responses by modulating dendritic cell maturation and function J. Immunol. 194 2015 4676 4687
35. F.S. Hodi, and et al. Improved survival with ipilimumab in patients with metastatic melanoma N. Engl. J. Med. 363 2010 711 723
36. E.J. Lipson, and C.G. Drake Ipilimumab: an anti-CTLA-4 antibody for metastatic melanoma Clin. Cancer Res. 17 2011 6958 6962
37. R. Roshani, and et al. Inflammatory cytokines in human pancreatic cancer Cancer Lett. 345 2014 157 163
38. J. Galon, and et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome Science 313 2006 1960 1964
39. B. Ebrahimi, and et al. Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis Cancer 101 2004 2727 2736
40. S.I. Grivennikov Inflammation and colorectal cancer: colitis-associated neoplasia Semin. Immunopathol. 35 2013 229 244
41. I.I. Ivanov, and et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine Cell Host Microbe 4 2008 337 349
42. I.I. Ivanov, and et al. Induction of intestinal Th17 cells by segmented filamentous bacteria Cell 139 2009 485 498
43. L.V. Hooper, and et al. Interactions between the microbiota and the immune system Science 336 2012 1268 1273
44. A.J. Macpherson, and N.L. Harris Interactions between commensal intestinal bacteria and the immune system Nat. Rev. Immunol. 4 2004 478 485
45. D.A. Hill, and D. Artis Intestinal bacteria and the regulation of immune cell homeostasis Annu. Rev. Immunol. 28 2010 623 667
46. S.I. Grivennikov, and et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth Nature 491 2012 254 258
47. A.D. Kostic, and et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment Cell Host Microbe 14 2013 207 215
48. X.J. Shen, and et al. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas Gut Microbes 1 2010 138 147
49. C. Jobin Colorectal cancer: looking for answers in the microbiota Cancer Discov. 3 2013 384 387
50. G. Zeller, and et al. Potential of fecal microbiota for early-stage detection of colorectal cancer Mol. Syst. Biol. 10 2014 766
51. J.P. Zackular, and et al. The human gut microbiome as a screening tool for colorectal cancer Cancer Prev. Res. 7 2014 1112 1121
52. C.M. Dejea, and et al. Microbiota organization is a distinct feature of proximal colorectal cancers Proc. Natl. Acad. Sci. U.S.A. 111 2014 18321 18326
53. C.H. Johnson, and et al. Metabolism links bacterial biofilms and colon carcinogenesis Cell Metab. 21 2015 891 897
54. J.L. Sonnenburg, and et al. Getting a grip on things: how do communities of bacterial symbionts become established in our intestine? Nat. Immunol. 5 2004 569 573
55. M.T. Villanueva Metabolism: bacterial biofilms may feed colon cancer Nat. Rev. Cancer 15 2015 320
56. S. Macfarlane, and J.F. Dillon Microbial biofilms in the human gastrointestinal tract J. Appl. Microbiol. 102 2007 1187 1196
57. B.S. Reddy, and et al. Colon carcinogenesis with azoxymethane and dimethylhydrazine in germ-free rats Cancer Res. 35 1975 287 290
58. M.R. Sacksteder Occurrence of spontaneous tumors in the germfree F344 rat J. Natl. Cancer Inst. 57 1976 1371 1373
59. L.K. Su, and et al. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene Science 256 1992 668 670
60. Min/+ mice Carcinogenesis 33 2012 1231 1238
61. S. Wu, and et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses Nat. Med. 15 2009 1016 1022
62. S. Singh, and et al. Comparative efficacy of pharmacologic interventions in preventing relapse of Crohn's disease after surgery: a systematic review and network meta-analysis Gastroenterology 148 2015 64 76
63. A.D. Kostic, and et al. The microbiome in inflammatory bowel disease: current status and the future ahead Gastroenterology 146 2014 1489 1499
64. X.W. Wu, and et al. Meta-analysis of ciprofloxacin in treatment of Crohn's disease Biomed. Rep. 3 2015 70 74
65. Y. Zhan, and et al. Gut microbiota protects against gastrointestinal tumorigenesis caused by epithelial injury Cancer Res. 73 2013 7199 7210
66. R.F. Schwabe, and C. Jobin The microbiome and cancer Nat. Rev. Cancer 13 2013 800 812
67. A. Boleij, and H. Tjalsma Gut bacteria in health and disease: a survey on the interface between intestinal microbiology and colorectal cancer Biol. Rev. Camb. Philos. Soc. 87 2012 701 730
68. G.Y. Chen, and et al. The innate immune receptor Nod1 protects the intestine from inflammation-induced tumorigenesis Cancer Res. 68 2008 10060 10067
69. P. Louis, and et al. The gut microbiota, bacterial metabolites and colorectal cancer Nat. Rev. Microbiol. 12 2014 661 672
70. G. Macfarlane, and G. Gibson Carbohydrate fermentation, energy transduction and gas metabolism in the human large intestine Gastrointestinal Microbiology 1997 Chapman and Hall 269 318
71. G.A. Weaver, and et al. Short chain fatty acid distributions of enema samples from a sigmoidoscopy population: an association of high acetate and low butyrate ratios with adenomatous polyps and colon cancer Gut 29 1988 1539 1543
72. T.L. Weir, and et al. Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults PLoS ONE 8 2013 e70803
73. N. Singh, and et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis Immunity 40 2014 128 139
74. D.R. Donohoe, and et al. A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner Cancer Discov. 4 2014 1387 1397
75. J.R. Lupton Microbial degradation products influence colon cancer risk: the butyrate controversy J. Nutr. 134 2004 479 482
76. A. Belcheva, and et al. Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells Cell 158 2014 288 299
77. C.L. Ohland, and C. Jobin Bugs and food: a recipe for cancer? Cell Metab. 20 2014 937 938
78. H.J. Freeman Effects of differing concentrations of sodium butyrate on 1,2-dimethylhydrazine-induced rat intestinal neoplasia Gastroenterology 91 1986 596 602
79. H.J. Flint, and et al. The role of the gut microbiota in nutrition and health Nat. Rev. Gastroenterol. Hepatol. 9 2012 577 589
80. E.W. Pomare, and et al. Carbohydrate fermentation in the human colon and its relation to acetate concentrations in venous blood J. Clin. Invest. 75 1985 1448 1454
81. K. Windey, and et al. Relevance of protein fermentation to gut health Mol. Nutr. Food Res. 56 2012 184 196
82. R. Hughes, and I.R. Rowland Metabolic activities of the gut microflora in relation to cancer Microb. Ecol. Health Dis. 2000 Suppl. 2 2000 179 185
83. M.L. Di Martino, and et al. Polyamines: emerging players in bacteria-host interactions Int. J. Med. Microbiol. 303 2013 484 491
84. A.E. Pegg Toxicity of polyamines and their metabolic products Chem. Res. Toxicol. 26 2013 1782 1800
85. M.S. Attene-Ramos, and et al. Hydrogen sulfide induces direct radical-associated DNA damage Mol. Cancer Res. 5 2007 455 459
86. E.A. Magee, and et al. Contribution of dietary protein to sulfide production in the large intestine: an in vitro and a controlled feeding study in humans Am. J. Clin. Nutr. 72 2000 1488 1494
87. Y.H. Loh, and et al. N-Nitroso compounds and cancer incidence: the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk Study Am. J. Clin. Nutr. 93 2011 1053 1061
88. B. Khor, and et al. Genetics and pathogenesis of inflammatory bowel disease Nature 474 2011 307 317
89. F.O. Nestle, and et al. Skin immune sentinels in health and disease Nat. Rev. Immunol. 9 2009 679 691
90. O. Pabst New concepts in the generation and functions of IgA Nat. Rev. Immunol. 12 2012 821 832
91. N.H. Salzman, and et al. Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa Semin. Immunol. 19 2007 70 83
92. M.M. Huycke, and H.R. Gaskins Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models Exp. Biol. Med. 229 2004 586 597
93. A.J. Cross, and et al. A prospective study of serum metabolites and colorectal cancer risk Cancer 120 2014 3049 3057
94. A.J. Cross, and et al. Metabolites of tobacco smoking and colorectal cancer risk Carcinogenesis 35 2014 1516 1522
95. K.A. Guertin, and et al. Serum biomarkers of habitual coffee consumption may provide insight into the mechanism underlying the association between coffee consumption and colorectal cancer Am. J. Clin. Nutr. 101 2015 1000 1011
96. A. Marcobal, and et al. A metabolomic view of how the human gut microbiota impacts the host metabolome using humanized and gnotobiotic mice ISME J. 7 2013 1933 1943
97. Y. Zhang, and et al. Metagenomic and metabolomic analysis of the toxic effects of trichloroacetamide-induced gut microbiome and urine metabolome perturbations in mice J. Proteome Res. 14 2015 1752 1761
98. J.P. Nougayrede, and et al. Escherichia coli induces DNA double-strand breaks in eukaryotic cells Science 313 2006 848 851
99. J.C. Arthur, and et al. Intestinal inflammation targets cancer-inducing activity of the microbiota Science 338 2012 120 123
100. G. Cuevas-Ramos, and et al. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells Proc. Natl. Acad. Sci. U.S.A. 107 2010 11537 11542
101. M. Bonnet, and et al. Colonization of the human gut by E. coli and colorectal cancer risk Clin. Cancer Res. 20 2014 859 867
102. E. Buc, and et al. High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer PLoS ONE 8 2013 e56964
103. A. Cougnoux, and et al. Small-molecule inhibitors prevent the genotoxic and protumoural effects induced by colibactin-producing bacteria Gut 2015 10.1136/gutjnl-2014-307241 Published online January 14, 2015
104. N.T. Baxter, and et al. Structure of the gut microbiome following colonization with human feces determines colonic tumor burden Microbiome 2 2014 20 PMID: 24967088
105. A. Couturier-Maillard, and et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer J. Clin. Invest. 123 2013 700 711
106. D. Payros, and et al. Maternally acquired genotoxic Escherichia coli alters offspring's intestinal homeostasis Gut Microbes 5 2014 313 325
107. F. Fostira, and et al. Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study Breast Cancer Res. Treat. 134 2012 353 362
108. T.R. Rebbeck, and et al. Modification of BRCA1-associated breast and ovarian cancer risk by BRCA1-interacting genes Cancer Res. 71 2011 5792 5805
109. R.S. van der Post, and et al. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers J. Med. Genet. 52 2015 361 374
110. P. Guilford, and et al. E-cadherin germline mutations in familial gastric cancer Nature 392 1998 402 405
111. N. Chun, and J.M. Ford Genetic testing by cancer site: stomach Cancer J. 18 2012 355 363
112. P.M. Choi, and M.P. Zelig Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention Gut 35 1994 950 954
113. A. Endo, and et al. Long-term monitoring of the human intestinal microbiota from the 2nd week to 13 years of age Anaerobe 28 2014 149 156
114. L.J. Funkhouser, and S.R. Bordenstein Mom knows best: the universality of maternal microbial transmission PLoS Biol. 11 2013 e1001631
115. S. Rautava, and et al. Microbial contact during pregnancy, intestinal colonization and human disease Nat. Rev. Gastroenterol. Hepatol. 9 2012 565 576
116. J.C. Arthur, and et al. Microbial genomic analysis reveals the essential role of inflammation in bacteria-induced colorectal cancer Nat. Commun. 5 2014 4724
117. M.R. Rubinstein, and et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin Cell Host Microbe 14 2013 195 206
118. A. Boleij, and et al. The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients Clin. Infect. Dis. 60 2015 208 215
119. S. Viaud, and et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide Science 342 2013 971 976
120. K. Ando, and et al. Humanizing bone marrow in immune-deficient mice Curr. Top. Microbiol. Immunol. 324 2008 77 86
121. M. Werner-Klein, and et al. Immune humanization of immunodeficient mice using diagnostic bone marrow aspirates from carcinoma patients PLoS ONE 9 2014 e97860
122. P.F. Justino, and et al. Treatment with Saccharomyces boulardii reduces the inflammation and dysfunction of the gastrointestinal tract in 5-fluorouracil-induced intestinal mucositis in mice Br. J. Nutr. 111 2014 1611 1621
123. N. Iida, and et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment Science 342 2013 967 970
124. E. Perez-Chanona, and C. Jobin From promotion to management: the wide impact of bacteria on cancer and its treatment Bioessays 36 2014 658 664
125. J.D. Hardcastle, and et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer Lancet 348 1996 1472 1477
126. O. Kronborg, and et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test Lancet 348 1996 1467 1471
127. J.S. Mandel, and et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study N. Engl. J. Med. 328 1993 1365 1371
128. R.M. Ned, and et al. Fecal DNA testing for colorectal cancer screening: the ColoSure test PLoS Curr. 3 2011 RRN1220
129. D.A. Ahlquist, and et al. Stool DNA and occult blood testing for screen detection of colorectal neoplasia Ann. Intern. Med. 149 2008 441 450 W481
130. T.F. Imperiale, and et al. Multitarget stool DNA testing for colorectal-cancer screening N. Engl. J. Med. 370 2014 1287 1297
131. V. Narayanan, and et al. Human fecal microbiome-based biomarkers for colorectal cancer Cancer Prev. Res. 7 2014 1108 1111
132. H.J. Flint The impact of nutrition on the human microbiome Nutr. Rev. 70 Suppl. 1 2012 S10 S13
133. K.P. Scott, and et al. The influence of diet on the gut microbiota Pharmacol. Res. 69 2013 52 60
134. A.W. Walker, and et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota ISME J. 5 2011 220 230
135. S. Kraus, and et al. Recent advances in personalized colorectal cancer research Cancer Lett. 347 2014 15 21
136. S. Sivanand, and et al. A validated tumorgraft model reveals activity of dovitinib against renal cell carcinoma Sci. Transl. Med. 4 2012 137ra175
137. J. Stebbing, and et al. Patient-derived xenografts for individualized care in advanced sarcoma Cancer 120 2014 2006 2015
138. S.J. Weroha, and et al. Tumorgrafts as in vivo surrogates for women with ovarian cancer Clin. Cancer Res. 20 2014 1288 1297
139. Y.N. You, and et al. Oncotype DX colon cancer assay for prediction of recurrence risk in patients with stage II and III colon cancer: a review of the evidence Surg. Oncol. 2015
140. R.M. Thomas, and et al. The canary in the coal mine: the growth of patient-derived tumorgrafts in mice predicts clinical recurrence after surgical resection of pancreatic ductal adenocarcinoma Ann. Surg. Oncol. 22 2015 1884 1892
141. J.R. Lee, and et al. Gut microbiota and tacrolimus dosing in kidney transplantation PLoS ONE 10 2015 e0122399
142. E. Catry, and et al. Ezetimibe and simvastatin modulate gut microbiota and expression of genes related to cholesterol metabolism Life Sci. 132 2015 77 84
143. C.E. Desch, and et al. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline J. Clin. Oncol. 23 2005 8512 8519
144. J.N. Primrose, and et al. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial JAMA 311 2014 263 270
145. G.Y. Locker, and et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer J. Clin. Oncol. 24 2006 5313 5327
146. R. Palmqvist, and et al. Prediagnostic levels of carcinoembryonic antigen and CA 242 in colorectal cancer: a matched case-control study Dis. Colon Rectum 46 2003 1538 1544
147. H. Sorbye, and O. Dahl Carcinoembryonic antigen surge in metastatic colorectal cancer patients responding to oxaliplatin combination chemotherapy: implications for tumor marker monitoring and guidelines J. Clin. Oncol. 21 2003 4466 4467
148. A.M. Ballesta, and et al. Carcinoembryonic antigen in staging and follow-up of patients with solid tumors Tumour Biol. 16 1995 32 41
149. A. Litvak, and et al. False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer J. Natl. Compr. Canc. Netw. 12 2014 907 913
150. M.A. Tempero, and et al. Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer Cancer Res. 47 1987 5501 5503
151. B. Zhang, and B. Yang Combined alpha fetoprotein testing and ultrasonography as a screening test for primary liver cancer J. Med. Screen. 6 1999 108 110
152. F. Farinati, and et al. Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither? Am. J. Gastroenterol. 101 2006 524 532
153. E. van Nood, and et al. Duodenal infusion of donor feces for recurrent Clostridium difficile N. Engl. J. Med. 368 2013 407 415
154. C.R. Raetz, and C. Whitfield Lipopolysaccharide endotoxins Annu. Rev. Biochem. 71 2002 635 700
155. F. Hayashi, and et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 Nature 410 2001 1099 1103
156. L. Alexopoulou, and et al. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3 Nature 413 2001 732 738
157. E.M. Moresco, and et al. Toll-like receptors Curr. Biol. 21 2011 R488 R493
158. E. Elinav, and et al. Regulation of the antimicrobial response by NLR proteins Immunity 34 2011 665 679
159. C. Galanos, and et al. Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities Eur. J. Biochem. 148 1985 1 5
160. A. Poltorak, and et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene Science 282 1998 2085 2088
161. A. Poltorak, and et al. Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region Blood Cells Mol. Dis. 24 1998 340 355
162. A.B. Schromm, and et al. The charge of endotoxin molecules influences their conformation and IL-6-inducing capacity J. Immunol. 161 1998 5464 5471
163. B. Beutler, and E.T. Rietschel Innate immune sensing and its roots: the story of endotoxin Nat. Rev. Immunol. 3 2003 169 176
164. G. Dranoff Cytokines in cancer pathogenesis and cancer therapy Nat. Rev. Cancer 4 2004 11 22
165. J.L. Langowski, and et al. IL-23 promotes tumour incidence and growth Nature 442 2006 461 465
166. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674